Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Reimbursement Briefs: National Coverage Updates; MolDx Meeting Request; Sleep Study Questions

This article was originally published in The Gray Sheet

Executive Summary

Hepatitis C virus screening national coverage supported in comments. Proposed decision memo delayed for percutaneous image-guided lumbar decompression for lumbar spinal stenosis national coverage determination. More reimbursement news.

Advertisement

Related Content

News Briefs: Biomet IPO; Hep C Screening Coverage; Valve Guidelines
CMS Proposes Noncoverage For Percutaneous Image-guided Lumbar Decompression
MolDx Labs Question Missing Medicare Payment Amounts For Some Test Codes
News Briefs: FDA Program Alignment Group; CardioMEMS Panel; HCV Coverage Analysis
Federal Task Force Recommends One-Time HCV Screening For All Baby Boomers
CMS Opens National Coverage Analysis For Percutaneous Image-Guided Lumbar Decompression
Personalized Medicine And Palmetto’s MolDx: Raising The Bar On Evidence

Topics

Advertisement
UsernamePublicRestriction

Register

MT032502

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel